BridgeMD
New treatment option for Rhegmatogenous Retinal Detachment
Official title Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy
ClinicalTrials.gov ID: NCT06694259
What this study is testing
- What it's testing
- Rhegmatogenous Retinal Detachment is a pathological condition in which the inner layers of the retina separate from its outermost layer due to fluid entering between these layers through a retinal tear. Retinal detachment is one of the most urgent conditions in ophthalmology; if left untreated, it leads to severe vision loss and blindness.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with rhegmatogenous retinal detachment with one or more tears within two clock hours, limited to the upper half of the retina
You likely can't join if
- Patients with tears in the lower half of the retina
- Patients with multiple retinal tears covering more than two clock hours
- Patients with developed proliferative vitreoretinopathy
- Patients with vitreous hemorrhage
- Patients with opaque optical media due to other conditions that could obstruct a detailed fundus examination or the procedure itself
- Patients unable to follow postoperative head positioning instructions
See the full eligibility criteria
- Patients with rhegmatogenous retinal detachment with one or more tears within two clock hours, limited to the upper half of the retina
- Patients with tears in the lower half of the retina
- Patients with multiple retinal tears covering more than two clock hours
- Patients with developed proliferative vitreoretinopathy
- Patients with vitreous hemorrhage
- Patients with opaque optical media due to other conditions that could obstruct a detailed fundus examination or the procedure itself
- Patients unable to follow postoperative head positioning instructions
- Patients under age of 18 years
The study team makes the final eligibility decision.
Where it's taking place
- Split, Croatia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Split, Croatia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.